IPAD-DB ID | S01250 |
Name | PQQ-TME |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 7 H 1 2 N 2 O 8 |
Molecular Weight | 372.3g/mol |
IUPAC Name | trimethyl 4, 5-dioxo-1H-pyrrolo[2, 3-f]quinoline-2, 7, 9-tricarboxylate |
InChI | InChI=1S/C17H12N2O8/c1-25-15(22)6-4-8(16(23)26-2)19-12-10(6)11-7(13(20)14(12)21)5-9(18-11)17(24)27-3/h4-5, 18H, 1-3H3 |
InChIKey | IYEWQFSKJDXIPI-UHFFFAOYSA-N |
Canonical SMILES | COC(=O)C1=CC(=NC2=C1C3=C(C=C(N3)C(=O)OC)C(=O)C2=O)C(=O)OC |
PubChem CID | 451469 |
DrugBank Accession Number | - |
CAS Registry Number | 74447-88-4 |
Molecular Weight(Computed by SwissADME) | 372.29 |
Hac(Computed by SwissADME) | 27 |
Volume(Computed by ADMETlab 2.0) | 342.87 |
Density(Computed by ADMETlab 2.0) | 1.085 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 13 |
nHet(Computed by ADMETlab 2.0) | 10 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 20 |
Flexibility(Computed by ADMETlab 2.0) | 0.3 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -4.597 |
LogD(Computed by ADMETlab 2.0) | 1.724 |
logP(Computed by ADMETlab 2.0) | 1.771 |
TPSA(Computed by SwissADME) | 141.72 |
Hbond Acceptor(Computed by SwissADME) | 9 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 6 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -7.91 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 1 |
Egan(Computed by SwissADME) | 1 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |